Multi event Drug Recall Enforcement Report Class II voluntary initiated by Sun Pharmaceutical Industries, Inc., originally initiated on 03-13-2020 for the product Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01. The product was recalled due to cgmp deviations: doxycycline capsules were not manufactured under current good manufacturing practice conditions.. The product was distributed nationwide and the recall is currently terminated.
Recall Enforcement Reports
| Recall Number |
Recall Initiation Date |
Report Date |
Recall Classification |
Quantity |
Product Description |
Recall Reason |
Status |
| D-1032-2020 | 03-13-2020 | 03-25-2020 | Class II | 624 bottles | Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01. | CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions. | Terminated |
| D-1033-2020 | 03-13-2020 | 03-25-2020 | Class II | 172,320 bottles | Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50. | CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions. | Terminated |
Recalled Products
